These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 12472368

  • 1. Pharmacological management of obesity.
    Hanif MW, Kumar S.
    Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacotherapy in the treatment of obesity].
    Hamann A.
    MMW Fortschr Med; 2006 Mar 02; 148(9):36-8. PubMed ID: 16566392
    [Abstract] [Full Text] [Related]

  • 4. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY, Thomas GN, Chan JC, Tomlinson B.
    Clin Ther; 2003 Jan 02; 25(1):58-80. PubMed ID: 12637112
    [Abstract] [Full Text] [Related]

  • 5. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO.
    MMW Fortschr Med; 1999 Dec 09; 141(49-50):32-6. PubMed ID: 10726144
    [Abstract] [Full Text] [Related]

  • 6. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
    Coutinho W.
    Arq Bras Endocrinol Metabol; 2009 Mar 09; 53(2):262-70. PubMed ID: 19466219
    [Abstract] [Full Text] [Related]

  • 7. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun 18; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract] [Full Text] [Related]

  • 8. [The obesity epidemics--do diet pills have a place in the treatment?].
    Tonstad S, Birkeland KI.
    Tidsskr Nor Laegeforen; 2000 Jun 30; 120(17):1997-2001. PubMed ID: 11008533
    [Abstract] [Full Text] [Related]

  • 9. Long-term pharmacotherapy for obesity and overweight.
    Padwal R, Li SK, Lau DC.
    Cochrane Database Syst Rev; 2003 Jun 30; (4):CD004094. PubMed ID: 14584004
    [Abstract] [Full Text] [Related]

  • 10. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM.
    Obes Res; 2000 Sep 30; 8(6):431-7. PubMed ID: 11011909
    [Abstract] [Full Text] [Related]

  • 11. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
    Wirth A.
    MMW Fortschr Med; 2003 Mar 06; 145(10):16. PubMed ID: 12688021
    [No Abstract] [Full Text] [Related]

  • 12. Long-term pharmacotherapy for obesity and overweight.
    Padwal R, Li SK, Lau DC.
    Cochrane Database Syst Rev; 2004 Mar 06; 2003(3):CD004094. PubMed ID: 15266516
    [Abstract] [Full Text] [Related]

  • 13. [Anti-obesity drugs: sibutramine and orlistat].
    Sempere I Verdú E, Palop Larrea V, Hidalgo Mora JJ, Martínez-Mir I.
    Med Clin (Barc); 2002 Mar 30; 118(11):437; author reply 437-8. PubMed ID: 11943108
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [What effect does losing weight have on hypertension?].
    Engeli S.
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):44. PubMed ID: 14587188
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Obesity: principles of drug therapy].
    Imoberdorf R, Ballmer PE.
    Ther Umsch; 2000 Aug 10; 57(8):522-5. PubMed ID: 11026090
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Weight loss medications--where do they fit in?
    Dixon JB.
    Aust Fam Physician; 2006 Aug 10; 35(8):576-9. PubMed ID: 16894428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.